Rimsys Inc., provider of the leading Regulatory Information Management (“RIM”) software designed specifically for medical technology (“MedTech”) companies, announced today it closed a $1.5 million investment round, led by Allos Ventures. The financing round will support Rimsys’ penetration of the MedTech RIM market through planned expansions of its product offering, sales, and marketing execution. Rimsys serves an expanding list of enterprise customers, including industry leaders such as Johnson & Johnson and Terumo.
“Complex regulatory challenges create barriers that delay product time-to-market, stall revenue growth and increase exposure to compliance risks for even the most experienced MedTech companies, said James Gianoutsos, founder & president of Rimsys. “Regulatory teams are in need of digital solutions that provide more efficient and compliant ways to
Rimsys’ solution seamlessly integrates with MedTech manufacturers’ existing quality management systems, product lifecycle management systems, and sales and distribution software systems. Rimsys’ robust digital platform, with its intuitive user interface and global intelligence, enables its customers to meet market entrance requirements and grow internationally. John McIlwraith, managing director at Allos Ventures will join Rimsys’ board of directors.
“The maze of global regulations covering medical technology is growing more complex and frequently results in dead ends and delays that can greatly impact commercialization of these products,” said McIlwraith. “This financing round will enable the company to further accelerate its momentum with large enterprise customers.”
For more information on Rimsys, please visit www.rimsys.io.
Rimsys is a world-leading RIM software platform for MedTech companies that digitizes, automates, and creates regulatory order. The only holistic RIM software for medical devices, in vitro diagnostics, and medical device software, Rimsys makes it easy to navigate the pillars of regulatory affairs including product registration, standards management, essential principles/GSPR, and regulatory intelligence.
About Allos Ventures:
Allos Ventures invests in early-stage technology companies based in the Midwest. Investments focus on B2B software companies at a Series A or B stage, augmenting the capital provided by seed and startup investors. In addition to the capital Allos provides, portfolio companies benefit from the extensive operating and business-building experience of the firm’s managing partners, who make themselves available as needed to support each portfolio company’s growth.